What is the intravenous dose and schedule of cisplatin in the GCD regimen?

Label:chem

Topic
Cisplatin is the platinum-based cytotoxic agent paired with gemcitabine.
Answer
Cisplatin 25 mg/m² IV on Days 1 and 8 of each 21-day cycle for up to eight cycles.
Return to Home Chemical List
Knowledge you may be interested in
What is the intravenous dose and schedule of durvalumab in the GCD regimen? What is the effect of Bisphenol S (BPS) on DNMT1 expression in Ishikawa cells? How does Bisphenol S (BPS) influence DNMT1 gene expression in trophoblastic cells? How does Bisphenol S (BPS) affect the viability of Ishikawa cells? What are the cytotoxic effects of Bisphenol S (BPS) on trophoblastic cells? What is Bisphenol S (BPS), and how does it relate to Bisphenol A (BPA)? Do oxytocin or carbetocin cause any significant changes in the electrocardiogram (ECG) during cesarean section? What is the observed effect size of maternal DHA intake on placental DHA content? Which placental phospholipid fatty acids showed significant correlations with maternal dietary intake? How was maternal dietary intake of fatty acids assessed, and which fatty acids were quantified? How many cycles of gemcitabine plus cisplatin are administered before switching to durvalumab monotherapy? What is curcumin, and how does it relate to metabolic syndrome (MetS)? What are the key metabolic effects of curcumin in rodent models of MetS? How does curcumin exert anti-inflammatory effects in MetS? What role does curcumin play in oxidative stress modulation? What are the dosing strategies and bioavailability challenges for curcumin? Are there safety concerns with curcumin? What is the primary function of gephyrin in inhibitory synapses, and how does it interact with GlyRs and GABAARs? How does strychnine affect GlyR clustering, and what are the limitations of using strychnine? What role does CaMKII play in GlyR clustering during early development?